The Great Divide: Will a Lifesaving HIV Drug Reach Everyone, or Just a Fortunate Few?

The Gene Whisperers: FDA Charts a Daring New Course for Medicine's Future

The Brain's Unseen Stories: Why a High-Profile MRI Matters at 79

The Unspoken Code: When Medicine Performs a Dangerous Dance with Deception

The Prior Authorization Maze: When 'Peer Review' Feels Like a Dead End

When Public Health Meets Private Profits: The Unsettling Dance of Wall Street and Global Well-being

The Medicare Maze: When Relief Is Just an "Experimental" Label Away

The Astonishing Disparity: Why Miebo's Price Tag is a World Apart Across the Atlantic

The Shifting Sands of Immunity: Why Our Younger Health Heroes Might Skip That Next COVID Shot

The Great Biotech Reckoning: Can Washington and Beijing Find Common Ground (Or Just More Friction)?

Echoes of a Pandemic: Seth Berkley on the Battle for Fair Doses and Tomorrow's Fight

The Double-Edged Sword of Progress: How New Dementia Treatments Could Unintentionally Deepen Stigma

The GLP-1 Revolution: A Price Tag, a Promise, and the Unfolding Future of Weight Management

The Shadow Returns: What Trump's Drug Pricing Encore Means for Your Medicine Cabinet

When Correlation Calls, But Causation Stays Silent: The Tylenol-Autism Conundrum

The Gathering Storm: NIH Budget Cuts Cast a Long Shadow Over Pharma's Future

Beyond the Call of Duty: Unpacking the Ethics and Economics of Compensating Healthy Volunteers in Medical Research

The Grand Illusion: How Profit Broke Healthcare

The Silent Erosion: How Vanishing Biodiversity Imperils Our Health and Future

Dr. Richard Besser Unveils Candid Truths on CDC's Future in Riveting Podcast Interview

Navigate the Medicare Maze: Your Essential Guide to Open Enrollment Success

Unmasking 'De-Animalization': The Haunting Reality of Lab Dogs

The Dawn of Precision: How Biomarkers are Revolutionizing Dementia Diagnosis

Beyond Cancer: Nkarta Pioneers a New Era for Autoimmune Diseases with Groundbreaking NK Cell Therapy

When Love Meets Leverage: The Heartbreaking Collision of Alzheimer's Care and Private Equity

Beyond the Jab: How a Public Health Revolution Saved Millions

Unlocking Cures: The Pharmaceutical Industry's Toughest Battle in the Global South

The Silent Revolution: AI Scribes Are Listening—Are We Ready for the Ethical Echoes?

The Unspoken Divide: When Hope Meets Harsh Reality in Breast Cancer Treatment

Beyond the Dotted Line: Reimagining Informed Consent in a Checkbox Culture

The Unseen Threat: Why a TB Expert is Sounding the Alarm on High-Risk Research

The Great Pharmaceutical Reversal: Onshoring's Costly Gamble with Drug Affordability

Telemedicine's Critical Lifeline Snapped: Coverage Waivers Fall Victim to Government Shutdown

The Uncharted Territory: Confronting the Investment Hurdles in Women's Health Innovation and Research

From Lab Coats to Likes: How Dr. Noc and Morgan McSweeney are Redefining Science Communication for Millions

The Unseen Toll: Unpacking Medicaid Work Requirements and Employer Incentives

Unveiling 'The Formula Book': Tom Frieden's Blueprint for Battling Public Health Threats

A Beacon of Hope: Transforming Child Surgical Care in El Salvador

Opinion: Pumping milk at JPM was a nightmare. It’s part of a bigger problem in the industry